Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 334

1.

Pentraxin-3 in Thrombolytic Therapy for Acute Ischemic Stroke: No Relation with Curative Effect and Prognosis.

Zhang CY, Han HD, Wang SY, Huang SR, Deng BQ.

Med Sci Monit. 2018 Jun 27;24:4427-4432. doi: 10.12659/MSM.909015.

2.

Circulating pentraxin 3 is positively associated with chronic hyperglycemia but negatively associated with plasma aldosterone concentration.

Takashi Y, Koga M, Matsuzawa Y, Saito J, Omura M, Nishikawa T.

PLoS One. 2018 May 1;13(5):e0196526. doi: 10.1371/journal.pone.0196526. eCollection 2018.

3.

PTX3: A Potential Biomarker in Thyroid Associated Ophthalmopathy.

Mou P, Chen Z, Jiang L, Cheng J, Wei R.

Biomed Res Int. 2018 Feb 20;2018:5961974. doi: 10.1155/2018/5961974. eCollection 2018.

4.

Impairment of PTX3 expression in osteoblasts: a key element for osteoporosis.

Scimeca M, Salustri A, Bonanno E, Nardozi D, Rao C, Piccirilli E, Feola M, Tancredi V, Rinaldi A, Iolascon G, Orlandi A, Gasbarra E, Maffulli N, Brandi ML, Tarantino U.

Cell Death Dis. 2017 Oct 12;8(10):e3125. doi: 10.1038/cddis.2017.514.

5.

Circulating levels of pentraxin-3 (PTX3) in patients with liver cirrhosis.

Narciso-Schiavon JL, Pereira JG, Silva TE, Bansho ETO, Morato EF, Pinheiro JT, Muraro-Wildner L, Bazzo ML, Dantas-Corrêa EB, Schiavon LL.

Ann Hepatol. 2017 Sep-Oct;16(5):780-787. doi: 10.5604/01.3001.0010.2789.

6.

Diagnostic value of Pentraxin-3 in patients with sepsis and septic shock in accordance with latest sepsis-3 definitions.

Hamed S, Behnes M, Pauly D, Lepiorz D, Barre M, Becher T, Lang S, Akin I, Borggrefe M, Bertsch T, Hoffmann U.

BMC Infect Dis. 2017 Aug 9;17(1):554. doi: 10.1186/s12879-017-2606-3.

7.

The clinical value of inflammatory biomarkers in coronary artery disease: PTX3 as a new inflammatory marker.

Guo T, Huang L, Liu C, Shan S, Li Q, Ke L, Cheng B.

Exp Gerontol. 2017 Oct 15;97:64-67. doi: 10.1016/j.exger.2017.07.018. Epub 2017 Aug 1.

PMID:
28778748
8.

Assessment of relationships between novel inflammatory markers and presence and severity of preeclampsia: Epicardial fat thickness, pentraxin-3, and neutrophil-to-lymphocyte ratio.

Cakmak HA, Dincgez Cakmak B, Abide Yayla C, Inci Coskun E, Erturk M, Keles I.

Hypertens Pregnancy. 2017 Aug;36(3):233-239. doi: 10.1080/10641955.2017.1321016. Epub 2017 Jun 1.

PMID:
28569615
9.

Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD.

Thulborn SJ, Dilpazir M, Haldar K, Mistry V, Brightling CE, Barer MR, Bafadhel M.

Int J Chron Obstruct Pulmon Dis. 2017 Apr 18;12:1199-1205. doi: 10.2147/COPD.S123528. eCollection 2017.

10.

Exercise reduced pentraxin 3 levels produced by endotoxin-stimulated human peripheral blood mononuclear cells in obese individuals.

Slusher AL, Shibata Y, Whitehurst M, Maharaj A, Quiles JM, Huang CJ.

Exp Biol Med (Maywood). 2017 Jun;242(12):1279-1286. doi: 10.1177/1535370217706963. Epub 2017 Apr 25.

11.

Pentraxin 3 and lipid profile status in pregnancy.

Jo YS, Cheon JY, Ahn JW, Kim Y, Lee GSR.

J Obstet Gynaecol. 2017 Aug;37(6):727-730. doi: 10.1080/01443615.2017.1291596. Epub 2017 Apr 19.

PMID:
28421853
12.

Pentraxin-3 levels are associated with vasculitis and disease activity in childhood-onset systemic lupus erythematosus.

Sahin S, Adrovic A, Barut K, Durmus S, Gelisgen R, Uzun H, Kasapcopur O.

Lupus. 2017 Sep;26(10):1089-1094. doi: 10.1177/0961203317699286. Epub 2017 Mar 14.

PMID:
28420068
13.

Serum Pentraxin 3 is associated with signs of arterial alteration in women with preeclampsia.

Akhter T, Wikström AK, Larsson M, Larsson A, Wikström G, Naessen T.

Int J Cardiol. 2017 Aug 15;241:417-422. doi: 10.1016/j.ijcard.2017.03.076. Epub 2017 Mar 24.

PMID:
28377191
14.

PENTRAXIN 3 AS A NEW CARDIOVASCULAR MARKER IN ADRENAL ADENOMAS.

Kizilgul M, Beysel S, Ozcelik O, Kan S, Apaydin M, Caliskan M, Ucan B, Sencar E, Ozdemir S, Cakal E.

Endocr Pract. 2017 Jun;23(6):662-668. doi: 10.4158/EP161713.OR. Epub 2017 Mar 23.

PMID:
28332877
15.

Interferon-α coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro.

Wirestam L, Enocsson H, Skogh T, Eloranta ML, Rönnblom L, Sjöwall C, Wetterö J.

Clin Exp Immunol. 2017 Jul;189(1):83-91. doi: 10.1111/cei.12957. Epub 2017 Mar 31.

16.

Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.

Deyab G, Hokstad I, Whist JE, Småstuen MC, Agewall S, Lyberg T, Bottazzi B, Meroni PL, Leone R, Hjeltnes G, Hollan I.

PLoS One. 2017 Feb 22;12(2):e0169830. doi: 10.1371/journal.pone.0169830. eCollection 2017.

17.

Association of Pentraxin 3 Gene Polymorphisms with Susceptibility to Diabetic Nephropathy.

Zhu H, Yu W, Xie Y, Zhang H, Bi Y, Zhu D.

Med Sci Monit. 2017 Jan 25;23:428-436.

18.

Plasma levels of pentraxin 3 in patients with spondyloarthritis.

Nisihara R, Skare TL, Zeni JO, Rasera H, Lidani K, Messias-Reason I.

Biomarkers. 2018 Feb;23(1):14-17. doi: 10.1080/1354750X.2016.1278265. Epub 2017 Jan 17.

PMID:
28043168
19.

Tunicamycin-induced Endoplasmic Reticulum Stress Upregulates the Expression of Pentraxin 3 in Human Retinal Pigment Epithelial Cells.

Hwang N, Kwon MY, Cha JB, Chung SW, Woo JM.

Korean J Ophthalmol. 2016 Dec;30(6):468-478. Epub 2016 Dec 6.

20.

Pentraxin 3 Activates JNK Signaling and Regulates the Epithelial-To-Mesenchymal Transition in Renal Fibrosis.

Hung TW, Tsai JP, Lin SH, Lee CH, Hsieh YH, Chang HR.

Cell Physiol Biochem. 2016;40(5):1029-1038. Epub 2016 Dec 12.

Supplemental Content

Support Center